Author:
Das Ram,Dhiman Ramesh C.,Savargaonkar Deepali,Anvikar Anupkumar R.,Valecha Neena
Funder
Indian Council of Medical Research (CMR), New Delhi
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference29 articles.
1. WHO. Guidelines for the treatment of malaria, second edition. Geneva, World Health Organization, 2010. http://www.who.int/malaria/publication/atos/978941547925/enindex.html.
2. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present and future. Lancet Infect Dis. 2004;4:327–36.
3. Adak T, Valecha N, Sharma VP. Plasmodium vivax polymorphism in a clinical drug trial. Clin Diagn Lab Immunol. 2001;8:891–4.
4. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007;195:927–33.
5. Nicholas JW. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10(297):135. doi: 10.1186/1475-2875-10-297 .
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献